Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) closed at $52.09 down -5.92% from its previous closing price of $55.37. In other words, the price has decreased by -$5.92 from its previous closing price. On the day, 1.16 million shares were traded. CRNX stock price reached its highest trading level at $55.465 during the session, while it also had its lowest trading level at $51.35.
Ratios:
For a deeper understanding of Crinetics Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.38 and its Current Ratio is at 16.38. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 06, 2024, initiated with a Buy rating and assigned the stock a target price of $68.
On January 16, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $50.
On December 21, 2023, Jefferies started tracking the stock assigning a Hold rating and target price of $35.Jefferies initiated its Hold rating on December 21, 2023, with a $35 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 02 ’24 when Struthers Richard Scott sold 10,000 shares for $57.57 per share. The transaction valued at 575,700 led to the insider holds 100,000 shares of the business.
Struthers Richard Scott bought 10,000 shares of CRNX for $572,700 on Dec 02 ’24. On Nov 22 ’24, another insider, Knight Jeff E., who serves as the Chief Operating Officer of the company, sold 501 shares for $56.52 each. As a result, the insider received 28,317 and left with 51,653 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRNX now has a Market Capitalization of 4830701568 and an Enterprise Value of 4020573952. Its current Enterprise Value per Revenue stands at 3869.657 whereas that against EBITDA is -13.204.
Stock Price History:
Over the past 52 weeks, CRNX has reached a high of $62.53, while it has fallen to a 52-week low of $32.92. The 50-Day Moving Average of the stock is -8.41%, while the 200-Day Moving Average is calculated to be 3.22%.
Shares Statistics:
For the past three months, CRNX has traded an average of 745.35K shares per day and 748300 over the past ten days. A total of 92.74M shares are outstanding, with a floating share count of 86.89M. Insiders hold about 6.31% of the company’s shares, while institutions hold 88.23% stake in the company. Shares short for CRNX as of 1732838400 were 6010613 with a Short Ratio of 8.06, compared to 1730332800 on 6944093. Therefore, it implies a Short% of Shares Outstanding of 6010613 and a Short% of Float of 6.6000000000000005.
